Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.

Add to Collection

2019 Dec 9 Others NP Kumar, K Moideen, A Nancy, V Viswanathan… - BMC Infectious …, 2019 - Springer 55

Full Author : ['Kumar, Nathella Pavan', 'Moideen, Kadar', 'Nancy, Arul', 'Viswanathan, Vijay', 'Shruthi, Basavaradhya S', 'Sivakumar, Shanmugam', 'Hissar, Syed', 'Kornfeld, Hardy', 'Babu, Subash']
Journal Title : BMC infectious diseases
Chapter : Section3
Journal Year : 2019
Cited by : 7.0

BACKGROUND: Ligands of the receptor for advanced glycation end products (RAGE) are key signalling molecules in the innate immune system but their role in tuberculosis-diabetes comorbidity (TB-DM) has not been investigated. METHODS: We examined the systemi..... Read More

Keywords : ["systemic rage ligand", "tuberculosis individual", "metformin therapy", "diabetes comorbidity", "antituberculosis treatment", "upregulate", "modulate"]
PubMed Link : https://link.springer.com/article/10.1186/s12879-019-4648-1
Google Scholar Link : https://scholar.google.com/scholar?cites=18026038030937270630&as_sdt=80005&sciodt=0,11&hl=en&num=20

Have a Question?

Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.